Loading clinical trials...
Loading clinical trials...
To learn about the safety and effects of low-dose sirolimus in participants with RUNX1-FPD.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
M.D. Anderson Cancer Center
NCT03000244 · Hematopoietic Stem Cell Transplantation, Tissue Donors
NCT07569055 · Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT06861257 · Pediatric Hematopoietic Stem Cell Transplantation, Malignant Disorders, and more
NCT06090669 · Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies
NCT07025538 · Hematopoietic and Lymphatic System Neoplasm
MD Anderson Cancer Center
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions